title: Tumor cell contamination in ovarian tissue cryopreserved before gonadotoxic treatment: should we systematically exclude ovarian autograft in a cancer survivor?
authors.forename: B
authors.initials: B
authors.lastname: Courbiere
authors.forename: T
authors.initials: T
authors.lastname: Prebet
authors.forename: M-J
authors.initials: MJ
authors.lastname: Mozziconacci
authors.forename: C
authors.initials: C
authors.lastname: Metzler-Guillemain
authors.forename: J
authors.initials: J
authors.lastname: Saias-Magnan
authors.forename: M
authors.initials: M
authors.lastname: Gamerre
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000633:toxicity; D015925:Cryopreservation; D005260:Female; D005298:Fertility / Q000187:drug effects; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy; D010053:Ovary / Q000637:transplantation*
chemical_list: D000970:Antineoplastic Agents